These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20497425

  • 1. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
    Ooi CC, Good NM, Williams DB, Lewanowitsch T, Cosgrove LJ, Lockett TJ, Head RJ.
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of butyrate analogues in HT-29 cancer cells.
    Ooi CC, Good NM, Williams DB, Lewanowitsch T, Cosgrove LJ, Lockett TJ, Head RJ.
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase.
    Lea MA, Tulsyan N.
    Anticancer Res; 1995 Apr; 15(3):879-83. PubMed ID: 7645975
    [Abstract] [Full Text] [Related]

  • 5. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W, Röske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C.
    Clin Cancer Res; 2008 Mar 15; 14(6):1669-77. PubMed ID: 18347167
    [Abstract] [Full Text] [Related]

  • 6. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.
    Oncol Rep; 2005 Jun 15; 13(6):1139-44. PubMed ID: 15870934
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K, Saatcioglu F.
    Prostate; 2005 Feb 15; 62(3):299-306. PubMed ID: 15389787
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J, Du C, Kang J, Wang J.
    Chem Biol Interact; 2008 Jan 10; 171(1):26-36. PubMed ID: 17961528
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
    Inoue H, Shiraki K, Ohmori S, Sakai T, Deguchi M, Yamanaka T, Okano H, Nakano T.
    Int J Mol Med; 2002 May 10; 9(5):521-5. PubMed ID: 11956660
    [Abstract] [Full Text] [Related]

  • 12. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells.
    Fung KY, Lewanowitsch T, Henderson ST, Priebe I, Hoffmann P, McColl SR, Lockett T, Head R, Cosgrove LJ.
    J Proteome Res; 2009 Mar 10; 8(3):1220-7. PubMed ID: 19195990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
    Spurling CC, Godman CA, Noonan EJ, Rasmussen TP, Rosenberg DW, Giardina C.
    Mol Carcinog; 2008 Feb 10; 47(2):137-47. PubMed ID: 17849419
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
    Klampfer L, Huang J, Shirasawa S, Sasazuki T, Augenlicht L.
    Cancer Res; 2007 Sep 15; 67(18):8477-85. PubMed ID: 17875686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.
    Valente S, Trisciuoglio D, Tardugno M, Benedetti R, Labella D, Secci D, Mercurio C, Boggio R, Tomassi S, Di Maro S, Novellino E, Altucci L, Del Bufalo D, Mai A, Cosconati S.
    ChemMedChem; 2013 May 15; 8(5):800-11. PubMed ID: 23526814
    [Abstract] [Full Text] [Related]

  • 20. In vitro studies on the inhibition of colon cancer by butyrate and carnitine.
    Roy MJ, Dionne S, Marx G, Qureshi I, Sarma D, Levy E, Seidman EG.
    Nutrition; 2009 May 15; 25(11-12):1193-201. PubMed ID: 19619983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.